Literature DB >> 770104

Drug disposition and liver disease.

G R Wilkinson, S Schenker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 770104     DOI： 10.3109/03602537508993754

Source DB:  PubMed          Journal:  Drug Metab Rev        ISSN： 0360-2532            Impact factor:   4.518


× No keyword cloud information.
  34 in total

Review 1.  Altered hepatic blood flow and drug disposition.

Authors:  A S Nies; D G Shand; G R Wilkinson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

2.  Kinetics of intravenous metoclopramide in patients with hepatic cirrhosis.

Authors:  F Albani; M R Tamè; R De Palma; M Bernardi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  H3 Propranolol serum levels following lidocaine administration in rats with CCL4 induced liver damage.

Authors:  A Kotsiou; M Tsamouri; S Anagnostopoulou; M Tzivras; E Vairactaris; C Tesseromatis
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

4.  Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease.

Authors:  M Homeida; C J Roberts; M Halliwell; A E Read; R A Branch
Journal:  Gut       Date:  1979-07       Impact factor: 23.059

Review 5.  Protein binding and kinetics of drugs in liver diseases.

Authors:  T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

6.  Pharmacokinetics of dihydroquinidine in congestive heart failure patients after intravenous quinidine administration.

Authors:  C T Ueda; B S Dzindzio
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

7.  Kinetics of 14C-glycocholic acid clearance in normal man and in patients with liver disease.

Authors:  I T Gilmore; R P Thompson
Journal:  Gut       Date:  1978-12       Impact factor: 23.059

Review 8.  Drug prescribing in hepatobiliary disease.

Authors:  R K Roberts; P V Desmond; S Schenker
Journal:  Drugs       Date:  1979-03       Impact factor: 9.546

9.  Effects of hepatic function on vancomycin clinical pharmacology.

Authors:  N Brown; D H Ho; K L Fong; L Bogerd; A Maksymiuk; R Bolivar; V Fainstein; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

10.  Clinical pharmacology of bruceantin by radioimmunoassay.

Authors:  K L Fong; D H Ho; R S Benjamin; N S Brown; A Bedikian; B S Yap; C L Wiseman; W Kramer; G P Bodey
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.